Safety Study of Cord Blood Units
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 500 patients (estimated)
- Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborators
- National Cancer Institute (NCI)
- Tags
- Allogeneic Stem Cell Transplant, Cord Blood
- Trial Type
- Treatment
- Last Update
- 2 months ago
- SparkCures ID
- 1581
- NCT Identifier
- NCT01861093
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.